Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
PIEZOs mediate neuronal sensing of blood pressure and the baroreceptor reflex
2018 StandoutScienceNobel
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
cGMP: The wayward child of the cyclic nucleotide family
1991
Triglycerides and Cardiovascular Disease
2011
Nitric oxide and atherosclerosis: An update
2006 Nobel
Relationship between insulin resistance and cardiac sympathetic nervous function in essential hypertension
1999
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
Universal Definition of Myocardial Infarction
2007 Standout
The Systemic Amyloidoses
1997 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
2015
Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
2007 Standout
ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance
2010
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
2006
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes
2007
Exercise Standards for Testing and Training
2013 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction
2001 Standout
Primary pulmonary hypertension
1988
Review of Trials in Chronic Heart Failure Showing Broad-Spectrum Anti-Inflammatory Approaches
2005
GIPC Interacts with the β1-Adrenergic Receptor and Regulates β1-Adrenergic Receptor-mediated ERK Activation
2003 StandoutNobel
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Obstructive sleep apnea and hypertrophic cardiomyopathy: A common and potential harmful combination
2012
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
ErbB2 is essential in the prevention of dilated cardiomyopathy
2002
N-Terminal Pro–B-Type Natriuretic Peptide and Long-Term Mortality in Stable Coronary Heart Disease
2005
Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis
2006
Chemoprotection from p53-dependent apoptosis: potential clinical applications of the p53 inhibitors 2 2Abbreviations: CP, cyclophosphamide; PFT, pifithrin-α or p53 inhibitor; HT, hyperthermia; HS, heat shock; HO, hypoxia; and HIF-1, hypoxia inducible factor.
2001
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Age- and gender-specific differences in left and right ventricular cardiac function and mass determined by cine magnetic resonance imaging
2000
Diabetes and Atherosclerosis
2002 Standout
Myocarditis
2011 Standout
Bladder cancer
2016 Standout
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
Arterial stiffness and the systolic hypertension syndrome
2004
The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary Syndromes
2001
Apoptosis
2002 Standout
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
Involvement of aldosterone in left ventricular hypertrophy of patients with end-stage renal failure treated with hemodialysis
1999
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
1996 Standout
Regulation of myocardial βARK1 expression in catecholamine-induced cardiac hypertrophy in transgenic mice overexpressing α1B-adrenergic receptors
2001 StandoutNobel
Origin and physiological roles of inflammation
2008 StandoutNature
Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease
1992
Myocarditis
2000 Standout
Myocardial Expression of Fas and Recovery of Left Ventricular Function in Patients With Recent-Onset Cardiomyopathy
2005
Hypertrophic Cardiomyopathy
2002 Standout
Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy
2002
Third Universal Definition of Myocardial Infarction
2012 Standout
β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection
2007 StandoutNobel
Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin
1995
MRI of Acute Myocarditis
2002
Arterial structure and function in end-stage renal disease
2002
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
1992 Standout
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
2005 Standout
Biomarkers in Heart Failure
2008 Standout
Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery
2005 Standout
Nociceptors: the sensors of the pain pathway
2010 StandoutNobel
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes
2006 Standout
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
2002 Standout
Myocarditis
2009 Standout
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Incidence of Ischemic Strokes in Hypertrophic Cardiomyopathy is Markedly Increased if Complicated by Atrial Fibrillation
1997
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Apoptosis and Heart Failure
2000
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Plasma triglyceride and coronary heart disease.
1991
Dietary influences on serum lipids and lipoproteins.
1990
ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance
2010
Hypertriglyceridemic HyperapoB: The Unappreciated Atherogenic Dyslipoproteinemia in Type 2 Diabetes Mellitus
2001
Progress in Genetic Studies of Pain and Analgesia
2008
Four Faces of Baroreflex Failure
2002
Comparison of the Associations of Apolipoprotein B and Non-High-Density Lipoprotein Cholesterol With Other Cardiovascular Risk Factors in Patients With the Metabolic Syndrome in the Insulin Resistance Atherosclerosis Study
2004
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
1997 Standout
Prediction of Indications for Valve Replacement Among Asymptomatic or Minimally Symptomatic Patients With Chronic Aortic Regurgitation and Normal Left Ventricular Performance
1998
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Complementary roles of gasotransmitters CO and H2S in sleep apnea
2017 StandoutNobel
Predictors of Disease Course in Patients With Acute Myocarditis
2000
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary
2006
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
2006 StandoutScience
Contrast Media–Enhanced Magnetic Resonance Imaging Visualizes Myocardial Changes in the Course of Viral Myocarditis
1998
Acetoxymethyl esters of phosphates, enhancement of the permeability and potency of cAMP.
1993 StandoutNobel
Works of Mareomi Hamada being referenced
First-pass Myocardial Perfusion Defect and Delayed Contrast Enhancement in Hypertrophic Cardiomyopathy Assessed with MRI
2003
Cardiomyocyte apoptosis with enhanced expression of P53 and bax in right ventricle after pulmonary arterial banding
1999
Alterations in expression of sarcoplasmic reticulum gene in Dahl rats during the transition from compensatory myocardial hypertrophy to heart failure
1997
Charakteristika der linksventrikulären systolischen und diastolischen Funktionen bei Patienten mit essentieller Hypertonie
1993
Mechanism of Atrial Fibrillation and Increased Incidence of Thromboembolism in Patients With Hypertrophic Cardiomyopathy.
1995
Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) in patients with coexistent hypertrophic cardiomyopathy and coronary spastic angina
2005
Role of Angiotensin II–Regulated Apoptosis Through Distinct AT 1 and AT 2 Receptors in Neointimal Formation
2002
Clinical significance of measurements of serum apolipoprotein A-I, A-II and B in hypertriglyceridemic male patients with and without coronary artery disease
1985
Direct evidence of impaired cardiac sympathetic innervation in essential hypertensive patients with left ventricular hypertrophy.
1998
Neurogenic Stunned Myocardium
2000
Left Ventricular Hypertrophy Precedes Other Target-Organ Damage in Primary Aldosteronism
1997
Insulin Resistance in Patients With Hypertrophic Cardiomyopthy
2004
Aortic Distensibility is Closely Related to the Progression of Left Ventricular Hypertrophy in Patients Receiving Hemodialysis
2000
Increased Secretion of Atrial and Brain Natriuretic Peptides during Acute Myocardial Ischaemia Induced by Dynamic Exercise in Patients with Angina Pectoris
1995
Association of the atrial natriuretic factor receptor with guanylate cyclase in solubilized rat glomerular membranes
1987
Transient U Wave Inversion During Treadmill Exercise Testing in Patients with Left Anterior Descending Coronary Artery Disease
2000
Is captopril effective in primary pulmonary hypertension?.
1982
Increased Circulating Soluble Form of Fas in Patients With Dilated Cardiomyopathy
1998
Contribution of non-cardiomyocyte apoptosis to cardiac remodelling that occurs in the transition from compensated hypertrophy to heart failure in spontaneously hypertensive rats
1999
Measurement of Cardiac Chamber Volumes by Cine Magnetic Resonance Imaging
1993
Precise Assessment of Myocardial Damage Associated with Secondary Cardiomyopathies by Use of Gd-DTPA-Enhanced Magnetic Resonance Imaging
1993
Blood Pressure Response to the Valsalva Maneuver in Pheochromocytoma and Pseudopheochromocytoma
1995
Plasma lipids and lipoproteins in Japanese male patients with coronary artery disease and in their relatives
1982